MRAI

Marpai, Inc. [MRAI] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MRAI Stock Summary

In the News

MRAI Financial details

Company Rating
-
Market Cap
22.97M
Income
-29.49M
Revenue
37.16M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
162
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-0.3
Forward P/E
-
PEG
0.23
P/S
0.29
P/B
-1.07
P/C
-
P/FCF
-0.29
Quick Ratio
0.23
Current Ratio
0.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-4.55
EPS next Y
-
EPS next Q
-
EPS this Y
-20.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-0.25%
EPS Q/Q
-33.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-93%
ROE
1714%
ROC
-2.08%
Gross Margin
35%
Oper. Margin
-87%
Profit Margin
-91%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.33-13.6
52W High
-
52W Low
-
RSI
40
Rel Volume
0.01
Avg Volume
898.29K
Volume
5.23K
Perf Week
-9.89%
Perf Month
-14.47%
Perf Quarter
60.78%
Perf Half Y
18.84%
-
-
-
-
Beta
5.385
-
-
Volatility
0.05%, 0.05%
Prev Close
0%
Price
0.82
Change
-4.65%

Something similar

Top by Market Cap
FB2A.DE
FXAIX
VOO
1YD.DE
EMBASSY.NS
Same Sector
VERU
C6O.DE
326030.KS
688185.SS
VITR.ST
Same Price Range
QPR1V.HE
SLRX
NUWE
1003.HK
1759.HK
Similar Market Cap
FRIMX
PXC.L
RNMC
BBUS.DE
ZNWD.L

Company Profile

Healthcare Medical - Healthcare Plans
  • Volume Average 898.29K
  • Market Capitalization 22.97M
  • Employee 162
  • CEO Mr. Damien Francis Lamendola
  • Headquarters New York,NY,US
  • IPO Date 2021-10-27
  • Website https://www.marpaihealth.com

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.